The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91–108. doi:10.1007/s12325-016-0441-3

Detalles Bibliográficos
Autores principales: Cea-Calvo, Luis, Carmona, Loreto, Calvo-Alén, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599446/
https://www.ncbi.nlm.nih.gov/pubmed/28819910
http://dx.doi.org/10.1007/s12325-017-0602-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599446/
https://www.ncbi.nlm.nih.gov/pubmed/28819910
http://dx.doi.org/10.1007/s12325-017-0602-z

Ejemplares similares